Millennium Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-295,879
| Closed | -$37.9M | – | 6038 |
|
|
2025
Q2 | $37.9M | Sell |
295,879
-395,516
| -57% | -$41.1M | 0.02% | 1007 |
|
|
2025
Q1 | $61.2M | Sell |
691,395
-45,969
| -6% | -$4.48M | 0.03% | 626 |
|
|
2024
Q4 | $64.3M | Buy |
737,364
+118,577
| +19% | +$10.9M | 0.03% | 636 |
|
|
2024
Q3 | $57.2M | Sell |
618,787
-8,839
| -1% | -$878K | 0.03% | 750 |
|
|
2024
Q2 | $67.6M | Buy |
627,626
+539,966
| +616% | +$54M | 0.03% | 614 |
|
|
2024
Q1 | $8.32M | Sell |
87,660
-12,485
| -12% | -$1.07M | ﹤0.01% | 2366 |
|
|
2023
Q4 | $9.24M | Sell |
100,145
-755,889
| -88% | -$49M | ﹤0.01% | 2261 |
|
|
2023
Q3 | $43M | Buy |
856,034
+623,499
| +268% | +$33.3M | 0.02% | 808 |
|
|
2023
Q2 | $14.7M | Buy |
232,535
+174,563
| +301% | +$9.49M | 0.01% | 1671 |
|
|
2023
Q1 | $2.61M | Sell |
57,972
-270,321
| -82% | -$12.2M | ﹤0.01% | 3180 |
|
|
2022
Q4 | $14.4M | Buy |
328,293
+221,486
| +207% | +$10.6M | 0.01% | 1753 |
|
|
2022
Q3 | $7.04M | Buy |
106,807
+67,884
| +174% | +$4.36M | ﹤0.01% | 2550 |
|
|
2022
Q2 | $1.97M | Sell |
38,923
-123,855
| -76% | -$7.26M | ﹤0.01% | 3725 |
|
|
2022
Q1 | $10.4M | Buy |
162,778
+130,844
| +410% | +$9.39M | 0.01% | 2128 |
|
|
2021
Q4 | $3.42M | Sell |
31,934
-56,517
| -64% | -$5.91M | ﹤0.01% | 3267 |
|
|
2021
Q3 | $9.09M | Sell |
88,451
-62,744
| -41% | -$5.84M | 0.01% | 2186 |
|
|
2021
Q2 | $13.3M | Buy |
151,195
+13,313
| +10% | +$1.22M | 0.01% | 1574 |
|
|
2021
Q1 | $13.4M | Buy |
137,882
+122,680
| +807% | +$12.2M | 0.01% | 1486 |
|
|
2020
Q4 | $1.71M | Sell |
15,202
-202,448
| -93% | -$21.3M | ﹤0.01% | 3365 |
|
|
2020
Q3 | $20.2K | Buy |
217,650
+151,788
| +230% | +$11.7M | 0.02% | 798 |
|
|
2020
Q2 | $5.14M | Buy |
65,862
+35,082
| +114% | +$2.37M | 0.01% | 1742 |
|
|
2020
Q1 | $1.8M | Buy |
+30,780
| New | +$1.98M | ﹤0.01% | 2097 |
|
|
2019
Q2 | – | Sell |
-73,615
| Closed | -$6.08M | – | 4067 |
|
|
2019
Q1 | $5.89M | Sell |
73,615
-23,981
| -25% | -$1.77M | 0.01% | 1644 |
|
|
2018
Q4 | $5.26M | Sell |
97,596
-39,063
| -29% | -$2.37M | 0.01% | 1552 |
|
|
2018
Q3 | $10.7M | Buy |
136,659
+129,085
| +1,704% | +$8.97M | 0.01% | 1270 |
|
|
2018
Q2 | $481K | Sell |
7,574
-56,836
| -88% | -$4.52M | ﹤0.01% | 3183 |
|
|
2018
Q1 | $5.91M | Buy |
+64,410
| New | +$5.55M | 0.01% | 1697 |
|
|
2017
Q4 | – | Sell |
-159,884
| Closed | -$11.1M | – | 3796 |
|
|
2017
Q3 | $11.1M | Buy |
+159,884
| New | +$8.54M | 0.02% | 1176 |
|
|
2017
Q2 | – | Sell |
-7,100
| Closed | -$284K | – | 3472 |
|
|
2017
Q1 | $284K | Buy |
+7,100
| New | +$254K | ﹤0.01% | 3064 |
|
|
2016
Q4 | – | Sell |
-22,003
| Closed | -$653K | – | 3346 |
|
|
2016
Q3 | $653K | Buy |
+22,003
| New | +$547K | ﹤0.01% | 2472 |
|
|
2015
Q4 | – | Sell |
-35,000
| Closed | -$747K | – | 3425 |
|
|
2015
Q3 | $747K | Sell |
35,000
-45,200
| -56% | -$1.25M | ﹤0.01% | 2446 |
|
|
2015
Q2 | $2.12M | Buy |
+80,200
| New | +$2.29M | ﹤0.01% | 1885 |
|
Other funds holding BPMC
IA
HNB
Millennium Management's BPMC Position: Q3 2025 in Review
Millennium Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 295,879 shares — an estimated $37.9M sold.
Millennium Management first reported a position in BPMC in Q2 2015 and held it in 32 quarters. The position peaked at $67.6M in Q2 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Millennium Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Millennium Management sold 295,879 Blueprint Medicines shares in Q3 2025, an estimated $37.9M.
- Millennium Management first reported a position in Blueprint Medicines in Q2 2015 and held it in 32 quarters.
- Millennium Management's Blueprint Medicines position peaked at $67.6M in Q2 2024.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.